Correlation Between Pfizer and ProPhase Labs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and ProPhase Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and ProPhase Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and ProPhase Labs, you can compare the effects of market volatilities on Pfizer and ProPhase Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of ProPhase Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and ProPhase Labs.

Diversification Opportunities for Pfizer and ProPhase Labs

0.91
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Pfizer and ProPhase is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and ProPhase Labs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProPhase Labs and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with ProPhase Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProPhase Labs has no effect on the direction of Pfizer i.e., Pfizer and ProPhase Labs go up and down completely randomly.

Pair Corralation between Pfizer and ProPhase Labs

Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.31 times more return on investment than ProPhase Labs. However, Pfizer Inc is 3.23 times less risky than ProPhase Labs. It trades about -0.05 of its potential returns per unit of risk. ProPhase Labs is currently generating about -0.1 per unit of risk. If you would invest  3,584  in Pfizer Inc on September 1, 2024 and sell it today you would lose (963.00) from holding Pfizer Inc or give up 26.87% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  ProPhase Labs

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
ProPhase Labs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ProPhase Labs has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pfizer and ProPhase Labs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and ProPhase Labs

The main advantage of trading using opposite Pfizer and ProPhase Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, ProPhase Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProPhase Labs will offset losses from the drop in ProPhase Labs' long position.
The idea behind Pfizer Inc and ProPhase Labs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Money Managers
Screen money managers from public funds and ETFs managed around the world